ライフサイエンスコーパス: aortoiliac

1 Preoperative baseline aortoiliac anatomic characteristics were reviewed for ea

2 lower-extremity revascularization procedure (aortoiliac and infrainguinal arterial occlusive disease)

3 ients were more likely to undergo repair for aortoiliac and isolated iliac aneurysms compared to Whit

4 In 70 patients referred for evaluation of aortoiliac aneurysm disease, multi-detector row computed

5 ack, Asian, and Hispanic patients undergoing aortoiliac aneurysm repair in the VQI from 2003 to 2019.

6 perative characteristics, and outcomes after aortoiliac aneurysm repair.

7 ported stent-graft is necessary to repair an aortoiliac aneurysm.

8 Twenty-five patients with ruptured aortoiliac aneurysms (18 aortic, 7 iliac) were managed u

9 hy and CT angiography following treatment of aortoiliac aneurysms with endoluminal stent-grafts.

10 Endovascular treatment of aortoiliac aneurysms with stent-graft devices may be an

11 of perigraft leakage following treatment of aortoiliac aneurysms with stent-grafts.

12 Renal transplantation after repair of aortoiliac aneurysms with traditional prosthetic vascula

13 reatment outcomes for patients with ruptured aortoiliac aneurysms.

14 Baseline aortoiliac arterial anatomic characteristics are fundame

15 r EVAR and the relationship between baseline aortoiliac arterial anatomy and post-EVAR AAA sac enlarg

16 lable in 24 patients, were compared with the aortoiliac arterial length after stent-graft deployment.

17 tector coil was advanced into isolated human aortoiliac arteries and coupled to a 1.5-T scanner.

18 The accurate quantification of blood flow in aortoiliac arteries is challenging but clinically releva

19 ropopliteal disease, but comparative data in aortoiliac arteries is lacking.

20 ose of iodinated contrast material, and mean aortoiliac attenuation were compared.

21 abbits underwent stenting of the nondiseased aortoiliac bifurcation with bioresorbable vascular scaff

22 ransplantation due to the presence of severe aortoiliac calcification.

23 Freedom from intervention was 73.9% for aortoiliac disease and 88.6% for femoropopliteal disease

24 eneity of data precluded pooled analysis for aortoiliac disease and QoL endpoints.

25 Although aortoiliac disease patients improved walking performance

26 tments have greater long-term durability for aortoiliac disease than femoral popliteal disease.

27 ains widespread, especially in patients with aortoiliac disease.

28 to 45% of patients with coronary disease or aortoiliac disease.

29 al intragraft stents were required in 31% of aortoiliac endovascular stent-grafts to correct stent-gr

30 Aortoiliac enhancement was evaluated qualitatively by us

31 efficient, and reproducible way to optimize aortoiliac enhancement while reducing contrast medium do

32 were grouped according to level of stenosis (aortoiliac, femoropopliteal, multilevel, or rest group w

33 Bilateral aortoiliac grafts and distal femoral arteriovenous fistu

34 reath-hold protocol improves the accuracy of aortoiliac inflow assessment, but low resolution limits

35 6, 9, and 12 months, ovariectomy resulted in aortoiliac intimal hyperplasia compared with sham (P<0.0

36 The aortoiliac length of the median luminal centerline (MLC)

37 eprocedural prediction of the postprocedural aortoiliac length with the SP was significantly more acc

38 ascular grafts are being used to manage some aortoiliac lesions formerly treated by aortofemoral or e

39 th polytetrafluoroethylene were placed in 11 aortoiliac lesions in nine male non-surgical candidates

40 ome 267 patients were eligible for analysis (aortoiliac n = 70, 26%; femoropopliteal n = 115, 43%; mu

41 s with non-ruptured and ruptured AAA (rAAA), aortoiliac occlusive disease (AOD), or normal abdominal

42 ofemoral bypasses in high-risk patients with aortoiliac occlusive disease and critical ischemia.

43 f increased risk of death were patients with aortoiliac occlusive disease and patients undergoing bil

44 lateral circulation in patients with chronic aortoiliac occlusive disease undergoing subclavian trans

45 ary 1993 and December 1997, 52 patients with aortoiliac occlusive disease were treated with endovascu

46 were abdominal aortic aneurysms and 125 were aortoiliac occlusive disease.

47 Of 111 patients with aortoiliac PAD randomly assigned to receive OMC, OMC plu

48 The shortest aortoiliac path length maintaining at least one radius d

49 Treatment for claudication that is due to aortoiliac peripheral artery disease (PAD) often relies

50 We randomly assigned 111 patients with aortoiliac peripheral artery disease to receive 1 of 3 t

51 ing performance than ST, even for those with aortoiliac peripheral artery disease.

52 Bilateral aortoiliac prosthetic grafts were implanted into five ba

53 1981 to September 1995, 2340 retroperitoneal aortoiliac reconstructions were performed in 2243 patien

54 am of body weight) for MR angiography of the aortoiliac region.

55 s of kidney transplantation in patients with aortoiliac stenosis are not well-studied.

56 Patients with end-stage renal disease and aortoiliac stenosis are often considered ineligible for

57 This study aimed to assess the impact of aortoiliac stenosis on graft and patient survival.

58 tudy, participants with a recently diagnosed aortoiliac stenosis underwent HFR-CEUS measurements of t

59 Patients with aortoiliac stenosis were classified using the Trans-Atla

60 Patients without aortoiliac stenosis were functioning as controls.

61 velocimetry is feasible in patients with an aortoiliac stenosis, but several challenges must be over

62 IV), or US velocimetry, in participants with aortoiliac stenosis.

63 in a patient with an endovascular bifurcated aortoiliac stent graft.

64 Findings from long-term experience with aortoiliac stent placement for treatment of chronic lowe

65 ed with PET images to improve delineation of aortoiliac tracer activity.

66 ents, were most likely to undergo repair for aortoiliac (W:23%, B:38%, A:31%, H:22%, P < 0.001) and i